Notable Upgrades: GlaxoSmithKline plc (GSK), Hologic, Inc. (HOLX), Apple (AAPL)

Drug maker GlaxoSmithKline plc (GSK) had its rating upgraded to ‘Buy’ from ‘Neutral’ by analysts at Goldman Sachs (GS) on Monday. GSK shares recently gained $0.20 to $47.58. In the past 52 weeks, shares of Brentford, the United Kingdom-based pharmaceutical company have traded between a low of $46.01 and a high of $56.73. Shares are […] View the full post at: Notable Upgrades: GlaxoSmithKline plc (GSK), Hologic, Inc. (HOLX), Apple (AAPL) No related posts.